Page 847 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

Index 825

Hepatobiliary tumors (Continued) Histiocytic diseases (Continued) Human multiple myeloma, 264–265
pathology and natural behavior for, genetics and biologic behavior, 794–795, Human papillomavirus (HPV), 26
795f
Human T-cell leukemia virus
455–456
VetBooks.ir bile duct tumors, 455–456 hemophagocytic, 792t, 797 Humanized monoclonal antibody,
(HTLV-1), 26
hepatocellular tumor, 455
history and clinical signs, 795
neuroendocrine tumors, 456 treatment and prognosis, 796–797 261–262
sarcomas, 456 immunophenotyping, 793 Hydromorphone, 299t
prognosis for, 458–460 reactive histiocytosis, 794 5-Hydroxytryptamine (5-HT), 296
bile duct tumors, 459 Histiocytic mast cell tumor, 394 Hydroxyurea, 196–197
hepatocellular tumors, 458–459, 459f view of cat with, 395f Hyperadrenocorticism (HAC), 565–569
neuroendocrine tumors, 459 Histiocytic sarcoma, 666t, 792t, 794–797 clinical findings and diagnostic evaluation,
sarcomas, 459–460 of dendritic/macrophage lineage, 144 in dogs, 566–567
therapy for, 458–460 diagnosis and staging, 795–796, 795f–796f in dog with ovarian-steroid tumor, 598
Hepatocellular carcinoma fine-needle aspiration of, 144f feline, 573
cause of, 101 genetics and biologic behavior, 794–795, pituitary-dependent, 568–569,
hepatitis B and C, 26 795f 569f
Hepatocellular tumors, 135 hemophagocytic, 792t, 797 pathogenesis of, 565–566
pathology and natural behavior of, history and clinical signs, 795 Hypercalcemia, 580–581
455–456 immunohistochemical markers/panels for, of malignancy
prognosis for, 458–459, 459f 72t–73t acidosis and, 100
therapy and prognosis for, 458–459 treatment and prognosis, 796–797 cause of, 100
therapy for, 458–459 Histiocytoma, 792t treatment of, 100–101, 100b
Hepatocyte growth factor receptor (MET), cutaneous lymphoma versus, 143–144 tumors associated with, 99b
533 fine-needle aspiration of, 143f Hyperchromasia, 131
Hepatoid cell, 134f Histochemical stain Hypercortisolism. see Hyperadrenocorticism
Hepatoid gland epithelioma, 134 immunohistochemistry as, 71–74 (HAC)
Hepatoid tumor, 134 types and use of, 71 Hyperestrogenism, 101, 628–629
Herb, 332 Histologically low-grade but biologically high- effects of, 629
Herbicide, 15 grade FSA, 434–435 Hyperfractionation, 211
lymphoma and, 92 Histone, 146–147 Hyperglobulinemia
HercepTest scoring systems, 606 acetylation/deacetylation of, 269 cause of, 102
Heritable cancer syndrome, 2 Histone deacetylase (HDAC), 269–270 tumors associated with, 99b
Heritable colon cancer, 10 inhibition of, 270 Hyperparathyroidism, 580–581
Heterochromatin, 269 Histone deacetylase inhibitors (HDACi), 546 Hyperplasia
HGPIN. see High-grade prostatic Histopathology, for intestinal tumors, 463 benign tumor versus, 63
intraepithelial neoplasia Hitchings, George, 182 composition of, 62
HHS. see Hemophagocytic histiocytic sarcoma Homeopathy feline, 617
HHV. see Human herpes virus benefits of, 335 histologic features of, 65t
HIFU. see High-intensity focused ultrasound evidence of, 335 malignant canine mammary neoplasms,
High-dose dexamethasone suppression test Homeostasis, 6 609
(HDDST), in hyperadrenocorticism, Hormonal carcinogenesis, 92–93 neoplasia versus, 63
566 androgens/testosterone, 19 Hypersomatotropism, 569
High-grade prostatic intraepithelial neoplasia estrogen and progesterone, 18 Hypersomatropism, 101–102
(HGPIN), 631 Hormonal testing, for adrenal gland neoplasia, Hyperthermia, 169
High-intensity focused ultrasound (HIFU), 571–572 Hyperthyroidism, feline, 577
179 Hormone exposure, cancer and, 92–93 Hypertrophic osteopathy
Histiocytic diseases, 791 Hormone receptors, 606–607 characteristics of, 106
background, 791, 792t Hospital-based case-control study, 86 signs of, 106
comparative aspects, 798 Hospitalization tumors associated with, 99b
cutaneous histiocytoma, 793 nutrition during, 304 x-ray of, 107f
cutaneous Langerhans cell histiocytosis, weight loss in cats, 307–308 Hyperviscosity syndrome, 102
792t, 793–794 Host gene, 55 Hypofractionation, 211
feline, 797 HPV. see Human papillomavirus Hypoglycemia
feline histiocytic sarcoma, 797 HRQOL. see Health-related quality of life cause of, 101
feline progressive histiocytosis, 792t, HSA. see Hemangiosarcoma tumors associated with, 99b
797, 797f Human epidermal growth factor receptor 2 Hypophysectomy
pulmonary Langerhans cell histiocytosis, (HER2), 606 for canine pituitary-dependent
792t, 797 canine osteosarcoma and, 526 hypercortisolism, 567
histiocytic differentiation, 791–793 Human herpes virus (HHV), 26 for feline acromegaly, 570–571
histiocytic sarcoma, 792t, 794–797 Human mast cell disorder Hypoproteinemia, 102
diagnosis and staging, 795–796, subtypes of, 397 Hypoxia, tumors becoming, 211
795f–796f treatment of, 397 Hypoxia-inducible factor-1α (HIF), 6